Skip to content
healthcare.dev

Nauzene

NDC 52389-242, Sodium Citrate, tablet, chewable, from Kobayashi Healthcare International, Inc..

Product NDC
52389-242
Status
Listed
Labeler
Kobayashi Healthcare International, Inc.
Dosage form
TABLET, CHEWABLE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M001
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/52389-242 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRISODIUM CITRATE DIHYDRATE230 mg/1

Pharmacologic classes

Acidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]

Package NDCNDC-11Package
52389-242-10523890242101 BLISTER PACK in 1 CARTON (52389-242-10) / 10 TABLET, CHEWABLE in 1 BLISTER PACK
52389-242-42523890242423 BLISTER PACK in 1 CARTON (52389-242-42) / 14 TABLET, CHEWABLE in 1 BLISTER PACK
52389-242-56523890242564 BLISTER PACK in 1 CARTON (52389-242-56) / 14 TABLET, CHEWABLE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 52389-242 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/52389-242 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 52389-242. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.